Alive Israel HealthTech Fund focuses on investing in advanced-stage HealthTech and digital health companies, both in Israel and globally, across areas like medical devices, diagnostics, digital health, healthcare IT, and AI/ML. Their strategy involves leveraging strategic partnerships with leading healthcare organizations and financial institutions to accelerate the clinical and commercial expansion of their portfolio companies.
100% of their portfolio is in Healthcare. Their most common stage is series-c (67% of deals). Average disclosed round size is $63.3M (across 3 rounds with reported amounts).
Portfolio
3
Fund Size
$150M
Top Stage
Series C
Last 12 Mo
0
Portfolio Breakdown
Stage Distribution
Investment Activity
DealsAvg Round Size
Portfolio
3 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 Magenta Medical | Growth | $105M | Jul 2024 |
| Magenta Medical | Series C | $55M | May 2023 |
 Medisafe | Series C | $30M | Feb 2021 |
Top Co-Investors
OrbiMed2 shared
Pitango VC1 shared
Novo Holdings1 shared
Viking Global Investors1 shared
RA Capital Management1 shared
JVC Investment Partners1 shared
Octopus Ventures1 shared
Sanofi Ventures1 shared
Menora Mivtachim1 shared
Pitango HealthTech1 shared
7wireVentures1 shared
Merck1 shared
TriVentures1 shared
Qualcomm Ventures1 shared
OurCrowd1 shared
Last updated: 10 April 2026